Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial - Jagannathan, Prasanna; Andrews, Jason R.; Bonilla, Hector; Hedlin, Haley; Jacobson, Karen B.; Balasubramanian, Vidhya; Purington, Natasha; Kamble, Savita; de Vries, Christiaan R.; Quintero, Orlando; Feng, Kent; Ley, Catherine; et al. (Nature communications, 2021)
Keywords: 692/308/2779/777; 692/699/255/2514; Adult; Aged; Antiviral Agents - administration & dosage; Confidence intervals; Coronaviruses; COVID-19; COVID-19 - drug therapy; COVID-19 - virology; Female; Humanities and Social Sciences; Humans; Injections, Subcutaneous; Interferon; Interleukins - administration & dosage; Male; Middle Aged; multidisciplinary; Outpatients; Placebos; Polyethylene Glycols - administration & dosage; SARS-CoV-2 - drug effects; SARS-CoV-2 - physiology; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Signs and symptoms; Single-Blind Method; Transaminase; Treatment Failure; Viral diseases; Virus Shedding - drug effects; Young Adult